Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

BACKGROUND: One of the significant tumor immune escape mechanisms and substantial barrier for successful immunotherapy is tumor-mediated inhibition of immune response through cell-to-cell or receptor/ligand interactions. Programmed death receptor-1 (PD-1) interaction with its ligands, PD-L1 and PD-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Mkrtichyan, Mikayel, Chong, Namju, Abu Eid, Rasha, Wallecha, Anu, Singh, Reshma, Rothman, John, Khleif, Samir N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019896/
https://www.ncbi.nlm.nih.gov/pubmed/24829751
http://dx.doi.org/10.1186/2051-1426-1-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019896/
https://www.ncbi.nlm.nih.gov/pubmed/24829751
http://dx.doi.org/10.1186/2051-1426-1-15

Ejemplares similares